Mark E Saad Axsome Therapeutics, Inc. (AXSM) insider trading activity

AXSM Quotes by TradingView

Mark E Saad is of Axsome Therapeutics, Inc.. Currently has a direct ownership of 10,002 shares of AXSM, which is worth approximately $896,579. The most recent transaction as insider was on Sep 11, 2024, when has been sold 11,016 shares (Common Stock) at a price of $91.31 per share, resulting in proceeds of $1,005,870. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $896,579

Mark E Saad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2024
SELL
Open market or private sale
$1,005,870 $91.31 p/Share
11,016 Reduced 52.41%
10,002 Common Stock
Sep 11 2024
BUY
Exercise of conversion of derivative security
$40,428 $3.67 p/Share
11,016 Added 34.39%
21,018 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$103,590 $34.53 p/Share
3,000 Added 23.07%
10,002 Common Stock

Also insider at

RMED
Ra Medical Systems, Inc. Healthcare
Director
MES

Mark E Saad

New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AXSM